Evidence map›Paper›PMID 28123548›Full record

ArticleOncology letters2017

DHA blocks TPA-induced cell invasion by inhibiting MMP-9 expression via suppression of the PPAR-γ/NF-κB pathway in MCF-7 cells.

Jin-Ki Hwang, Hong-Nu Yu, Eun-Mi Noh, Jeong-Mi Kim, On-Yu Hong, Hyun Jo Youn, Sung Hoo Jung, Kang-Beom Kwon, Jong-Suk Kim, Young-Rae Lee

Open access · diamondAbstract read
In one paragraph

Article in Oncology letters, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 39 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Jin-Ki HwangCenter for Metabolic Function Regulation, Wonkwang University School of Medicine, Iksan, Jeonbuk 570-749, Republic of Korea.
Hong-Nu YuDepartment of Oncology Medicine, Xinhua Hospital Affiliated to Dalian University, Dalian, Liaoning 116021, P.R. China.
Eun-Mi NohCenter for Metabolic Function Regulation, Wonkwang University School of Medicine, Iksan, Jeonbuk 570-749, Republic of Korea.
Jeong-Mi KimCenter for Metabolic Function Regulation, Wonkwang University School of Medicine, Iksan, Jeonbuk 570-749, Republic of Korea.
On-Yu HongDepartment of Biochemistry, Institute of Medical Science, Chonbuk National University Medical School, Jeonju, Jeonbuk 560-182, Republic of Korea.
Hyun Jo YounDepartment of Surgery, Division of Breast Thyroid Surgery, Chonbuk National University Medical School, Jeonju, Jeonbuk 560-182, Republic of Korea.
Sung Hoo JungDepartment of Surgery, Division of Breast Thyroid Surgery, Chonbuk National University Medical School, Jeonju, Jeonbuk 560-182, Republic of Korea.
Kang-Beom KwonCenter for Metabolic Function Regulation, Wonkwang University School of Medicine, Iksan, Jeonbuk 570-749, Republic of Korea; Department of Korean Physiology, School of Korean Medicine, Wonkwang University, Iksan, Jeonbuk 570-749, Republic of Korea.
Jong-Suk KimDepartment of Biochemistry, Institute of Medical Science, Chonbuk National University Medical School, Jeonju, Jeonbuk 560-182, Republic of Korea.
Young-Rae LeeCenter for Metabolic Function Regulation, Wonkwang University School of Medicine, Iksan, Jeonbuk 570-749, Republic of Korea; Department of Oral Biochemistry, Institute of Biomaterials Implant, School of Dentistry, Wonkwang University, Iksan, Jeonbuk 570-749, Republic of Korea.
Wonkwang University · KRJeonbuk National University · KRDalian University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Docosahexaenoic acid (DHA) is an omega-3 fatty acid that is considered to have applications in cancer prevention and treatment. The beneficial effects of DHA against cancer metastasis are well established; however, the mechanisms underlying these effects in breast cancer are not clear. Cell invasion is critical for neoplastic metastasis, and involves the degradation of the extracellular matrix by matrix metalloproteinase (MMP)-9. The present study investigated the inhibitory effect of DHA on MMP-9 expression and cell invasion induced by 12-

Indexed as

DHAinvasionMCF-7MMP-9NF-κBPPAR-γ

Identifiers

PMID28123548
PMCPMC5245160
OpenAlexW2552965505

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.